Neurobehavioral comorbidities of epilepsy: Role of inflammation

Epilepsia

Volumn 58, Issue , 2017, Pages 48-56

  Mazarati, Andrey M ^a   Lewis, Megan L ^b   Pittman, Quentin J ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

Autism; Autism spectrum disorder; Cytokines; Depression; Inflammation; Maternal immune activation; Seizures

Indexed keywords

ANTIDEPRESSANT AGENT; ANTIINFLAMMATORY AGENT; SEROTONIN; BIOLOGICAL MARKER;

ANTIDEPRESSANT ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ARTICLE; AUTISM; BRAIN FUNCTION; DEPRESSION; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; ENCEPHALITIS; ENVIRONMENTAL FACTOR; EPILEPSY; HEREDITY; HUMAN; IMMUNE RESPONSE; META ANALYSIS (TOPIC); NEUROPATHOLOGY; NONHUMAN; PREGNANCY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SEROTONINERGIC SYSTEM; AUTISM SPECTRUM DISORDER; BRAIN; COMORBIDITY; DEPRESSIVE DISORDER; FEMALE; IMMUNOLOGY; NEUROGENIC INFLAMMATION; NEWBORN; PRENATAL EXPOSURE; RISK FACTOR;

AUTISM SPECTRUM DISORDER; BIOMARKERS; BRAIN; COMORBIDITY; DEPRESSIVE DISORDER; EPILEPSY; FEMALE; HUMANS; INFANT, NEWBORN; NEUROGENIC INFLAMMATION; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RISK FACTORS;

EID: 85021730866     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/epi.13786     Document Type: Article

References (140)

1. Najjar S, Pearlman DM, Alper K, et al. Neuroinflammation and psychiatric illness. J Neuroinflammation 2013;10:43.
2. Tellez-Zenteno JF, Patten SB, Jette N, et al. Psychiatric comorbidity in epilepsy: a population-based analysis. Epilepsia 2007;48:2336–2344.
3. Selassie AW, Wilson DA, Martz GU, et al. Epilepsy beyond seizure: a population-based study of comorbidities. Epilepsy Res 2014;108:305–315.
4. Nickels KC, Zaccariello MJ, Hamiwka LD, et al. Cognitive and neurodevelopmental comorbidities in paediatric epilepsy. Nat Rev Neurol 2016;12:465–476.
5. Rai D, Kerr MP, McManus S, et al. Epilepsy and psychiatric comorbidity: a nationally representative population-based study. Epilepsia 2012;53:1095–1103.
6. Tuchman R, Cuccaro M. Epilepsy and autism: neurodevelopmental perspective. Curr Neurol Neurosci Rep 2011;11:428–434.
7. Kanner AM. Depression in epilepsy: prevalence, clinical semiology, pathogenic mechanisms, and treatment. Biol Psychiatry 2003;54:388–398.
8. Kanner AM, Schachter SC, Barry JJ, et al. Depression and epilepsy: epidemiologic and neurobiologic perspectives that may explain their high comorbid occurrence. Epilepsy Behav 2012;24:156–168.
9. Christensen DL, Baio J, Van Naarden Braun K, et al. Prevalence and characteristics of autism spectrum disorder among children aged 8 years-autism and developmental disabilities monitoring network, 11 sites, United States, 2012. MMWR Surveill Summ 2016;65:1–23.
10. Taft LT, Cohen HJ. Hypsarrhythmia and infantile autism: a clinical report. J Autism Child Schizophr 1971;1:327–336.
11. Knobloch H, Pasamanick B. Some etiologic and prognostic factors in early infantile autism and psychosis. Pediatrics 1975;55:182–191.
12. Deykin EY, MacMahon B. The incidence of seizures among children with autistic symptoms. Am J Psychiatry 1979;136:1310–1312.
13. Kohane IS, McMurry A, Weber G, et al. The co-morbidity burden of children and young adults with autism spectrum disorders. PLoS ONE 2012;7:e33224.
14. Thomas S, Hovinga ME, Rai D, et al. Brief report: prevalence of co-occurring epilepsy and autism spectrum disorder: the U.S. National Survey of Children's Health 2011–2012. J Autism Dev Disord 2017;47:224–229.
15. Sundelin HE, Larsson H, Lichtenstein P, et al. Autism and epilepsy: a population-based nationwide cohort study. Neurology 2016;87:192–197.
16. Bolton PF, Carcani-Rathwell I, Hutton J, et al. Epilepsy in autism: features and correlates. Br J Psychiatry 2011;198:289–294.
17. Chez MG, Chang M, Krasne V, et al. Frequency of epileptiform EEG abnormalities in a sequential screening of autistic patients with no known clinical epilepsy from 1996 to 2005. Epilepsy Behav 2006;8:267–271.
18. Frye RE, Casanova MF, Fatemi SH, et al. Neuropathological mechanisms of seizures in autism spectrum disorder. Front Neurosci 2016;10:192.
19. Buckley AW, Holmes GL. Epilepsy and autism. Cold Spring Harb Perspect Med 2016;6:a022749.
20. Haar S, Berman S, Behrmann M, et al. Anatomical abnormalities in autism? Cereb Cortex 2016;26:1440–1452.
21. David N, Schneider TR, Peiker I, et al. Variability of cortical oscillation patterns: a possible endophenotype in autism spectrum disorders? Neurosci Biobehav Rev 2016;71:590–600.
22. Abdallah MW, Larsen N, Mortensen EL, et al. Neonatal levels of cytokines and risk of autism spectrum disorders: an exploratory register-based historic birth cohort study utilizing the Danish Newborn Screening Biobank. J Neuroimmunol 2012;252:75–82.
23. Maximo JO, Cadena EJ, Kana RK. The implications of brain connectivity in the neuropsychology of autism. Neuropsychol Rev 2014;24:16–31.
24. Ruskin DN, Svedova J, Cote JL, et al. Ketogenic diet improves core symptoms of autism in BTBR mice. PLoS ONE 2013;8:e65021.
25. Meyer U. Prenatal poly(i:C) exposure and other developmental immune activation models in rodent systems. Biol Psychiatry 2014;75:307–315.
26. Malkova NV, Yu CZ, Hsiao EY, et al. Maternal immune activation yields offspring displaying mouse versions of the three core symptoms of autism. Brain Behav Immun 2012;26:607–616.
27. Washington J 3rd, Kumar U, Medel-Matus JS, et al. Cytokine-dependent bidirectional connection between impaired social behavior and susceptibility to seizures associated with maternal immune activation in mice. Epilepsy Behav 2015;50:40–45.
28. Hirota T, Veenstra-Vanderweele J, Hollander E, et al. Antiepileptic medications in autism spectrum disorder: a systematic review and meta-analysis. J Autism Dev Disord 2014;44:948–957.
29. Rathouz PJ, Zhao Q, Jones JE, et al. Cognitive development in children with new onset epilepsy. Dev Med Child Neurol 2014;56:635–641.
30. Kalynchuk LE. Long-term amygdala kindling in rats as a model for the study of interictal emotionality in temporal lobe epilepsy. Neurosci Biobehav Rev 2000;24:691–704.
31. Smith GD, White J, Lugo JN. Superimposing status epilepticus on neuron subset-specific PTEN haploinsufficient and wild type mice results in long-term changes in behavior. Sci Rep 2016;6:36559.
32. Lee BH, Smith T, Paciorkowski AR. Autism spectrum disorder and epilepsy: disorders with a shared biology. Epilepsy Behav 2015;47:191–201.
33. Berg AT, Shinnar S, Hauser WA, et al. A prospective study of recurrent febrile seizures. N Engl J Med 1992;327:1122–1127.
34. Reid AY, Galic MA, Teskey GC, et al. Febrile seizures: current views and investigations. Can J Neurol Sci 2009;36:679–686.
35. Verity CM, Greenwood R, Golding J. Long-term intellectual and behavioral outcomes of children with febrile convulsions. N Engl J Med 1998;338:1723–1728.
36. Ellenberg JH, Nelson KB. Febrile seizures and later intellectual performance. Arch Neurol 1978;35:17–21.
37. Chang YC, Guo NW, Huang CC, et al. Neurocognitive attention and behavior outcome of school-age children with a history of febrile convulsions: a population study. Epilepsia 2000;41:412–420.
38. Verrotti A, Matricardi S, Rinaldi VE, et al. Neuropsychological impairment in childhood absence epilepsy: review of the literature. J Neurol Sci 2015;359:59–66.
39. Heida JG, Teskey GC, Pittman QJ. Febrile convulsions induced by the combination of lipopolysaccharide and low-dose kainic acid enhance seizure susceptibility, not epileptogenesis, in rats. Epilepsia 2005;46:1898–1905.
40. Reid AY, Riazi K, Campbell TG, et al. Increased excitability and molecular changes in adult rats after a febrile seizure. Epilepsia 2013;54:e45–e48.
41. Auvin S, Porta N, Nehlig A, et al. Inflammation in rat pups subjected to short hyperthermic seizures enhances brain long-term excitability. Epilepsy Res 2009;86:124–130.
42. Rajab E, Abdeen Z, Hassan Z, et al. Cognitive performance and convulsion risk after experimentally-induced febrile-seizures in rat. Int J Dev Neurosci 2014;34:19–23.
43. Dube CM, Ravizza T, Hamamura M, et al. Epileptogenesis provoked by prolonged experimental febrile seizures: mechanisms and biomarkers. J Neurosci 2010;30:7484–7494.
44. Holmes GL. Effect of seizures on the developing brain and cognition. Semin Pediatr Neurol 2016;23:120–126.
45. Bernard PB, Benke TA. Early life seizures: evidence for chronic deficits linked to autism and intellectual disability across species and models. Exp Neurol 2015;263:72–78.
46. Bernard PB, Castano AM, Beitzel CS, et al. Behavioral changes following a single episode of early-life seizures support the latent development of an autistic phenotype. Epilepsy Behav 2015;44:78–85.
47. Lugo JN, Swann JW, Anderson AE. Early-life seizures result in deficits in social behavior and learning. Exp Neurol 2014;256:74–80.
48. Galic MA, Riazi K, Henderson AK, et al. Viral-like brain inflammation during development causes increased seizure susceptibility in adult rats. Neurobiol Dis 2009;36:343–351.
49. Dupuis N, Mazarati A, Desnous B, et al. Pro-epileptogenic effects of viral-like inflammation in both mature and immature brains. J Neuroinflammation 2016;13:307.
50. Galic MA, Riazi K, Heida JG, et al. Postnatal inflammation increases seizure susceptibility in adult rats. J Neurosci 2008;28:6904–6913.
51. Auvin S, Mazarati A, Shin D, et al. Inflammation enhances epileptogenesis in the developing rat brain. Neurobiol Dis 2010;40:303–310.
52. Edwards HE, Dortok D, Tam J, et al. Prenatal stress alters seizure thresholds and the development of kindled seizures in infant and adult rats. Horm Behav 2002;42:437–447.
53. Salzberg M, Kumar G, Supit L, et al. Early postnatal stress confers enduring vulnerability to limbic epileptogenesis. Epilepsia 2007;48:2079–2085.
54. Jones NC, Kumar G, O'Brien TJ, et al. Anxiolytic effects of rapid amygdala kindling, and the influence of early life experience in rats. Behav Brain Res 2009;203:81–87.
55. Huang LT, Holmes GL, Lai MC, et al. Maternal deprivation stress exacerbates cognitive deficits in immature rats with recurrent seizures. Epilepsia 2002;43:1141–1148.
56. Doenni VM, Gray JM, Song CM, et al. Deficient adolescent social behavior following early-life inflammation is ameliorated by augmentation of anandamide signaling. Brain Behav Immun 2016;58:237–247.
57. Dinel AL, Joffre C, Trifilieff P, et al. Inflammation early in life is a vulnerability factor for emotional behavior at adolescence and for lipopolysaccharide-induced spatial memory and neurogenesis alteration at adulthood. J Neuroinflammation 2014;11:155.
58. Atladottir HO, Thorsen P, Ostergaard L, et al. Maternal infection requiring hospitalization during pregnancy and autism spectrum disorders. J Autism Dev Disord 2010;40:1423–1430.
59. Atladottir HO, Henriksen TB, Schendel DE, et al. Autism after infection, febrile episodes, and antibiotic use during pregnancy: an exploratory study. Pediatrics 2012;130:e1447–e1454.
60. Patterson PH. Maternal infection and autism. Brain Behav Immun 2012;26:393.
61. Lowe GC, Luheshi GN, Williams S. Maternal infection and fever during late gestation are associated with altered synaptic transmission in the hippocampus of juvenile offspring rats. Am J Physiol Regul Integr Comp Physiol 2008;295:R1563–R1571.
62. Yin P, Zhang XT, Li J, et al. Maternal immune activation increases seizure susceptibility in juvenile rat offspring. Epilepsy Behav 2015;47:93–97.
63. Yin P, Liu J, Li Z, et al. Prenatal immune challenge in rats increases susceptibility to seizure-induced brain injury in adulthood. Brain Res 2013;1519:78–86.
64. Pineda E, Shin D, You SJ, et al. Maternal immune activation promotes hippocampal kindling epileptogenesis in mice. Ann Neurol 2013;74:11–19.
65. Tellez-Zenteno JF, Matijevic S, Wiebe S. Somatic comorbidity of epilepsy in the general population in Canada. Epilepsia 2005;46:1955–1962.
66. Scheid R, Teich N. Neurologic manifestations of ulcerative colitis. Eur J Neurol 2007;14:483–493.
67. Riazi K, Galic MA, Pittman QJ. Contributions of peripheral inflammation to seizure susceptibility: cytokines and brain excitability. Epilepsy Res 2010;89:34–42.
68. D'Mello C, Swain MG. Immune-to-brain communication pathways in inflammation-associated sickness and depression. Curr Top Behav Neurosci 2016;31:73–94.
69. Konat G. Cerebral response to peripheral challenge with a viral mimetic. Neurochem Res 2016;41:144–155.
70. Vezzani A, Aronica E, Mazarati A, et al. Epilepsy and brain inflammation. Exp Neurol 2011;244:11–21.
71. Wilcox KS, Vezzani A. Does brain inflammation mediate pathological outcomes in epilepsy? Adv Exp Med Biol 2014;813:169–183.
72. Devinsky O, Vezzani A, Najjar S, et al. Glia and epilepsy: excitability and inflammation. Trends Neurosci 2013;36:174–184.
73. Walker A, Russmann V, Deeg CA, et al. Proteomic profiling of epileptogenesis in a rat model: focus on inflammation. Brain Behav Immun 2016;53:138–158.
74. Morgan JT, Chana G, Pardo CA, et al. Microglial activation and increased microglial density observed in the dorsolateral prefrontal cortex in autism. Biol Psychiatry 2010;68:368–376.
75. Vargas DL, Nascimbene C, Krishnan C, et al. Neuroglial activation and neuroinflammation in the brain of patients with autism. Ann Neurol 2005;57:67–81.
76. Voineagu I, Wang X, Johnston P, et al. Transcriptomic analysis of autistic brain reveals convergent molecular pathology. Nature 2011;474:380–384.
77. Meltzer A, Van de Water J. The role of the immune system in autism spectrum disorder. Neuropsychopharmacology 2017;42:284–298.
78. Claypoole LD, Zimmerberg B, Williamson LL. Neonatal lipopolysaccharide treatment alters hippocampal neuroinflammation, microglia morphology and anxiety-like behavior in rats selectively bred for an infantile trait. Brain Behav Immun 2017;59:135–146.
79. Roque A, Ochoa-Zarzosa A, Torner L. Maternal separation activates microglial cells and induces an inflammatory response in the hippocampus of male rat pups, independently of hypothalamic and peripheral cytokine levels. Brain Behav Immun 2016;55:39–48.
80. Meyer U, Nyffeler M, Engler A, et al. The time of prenatal immune challenge determines the specificity of inflammation-mediated brain and behavioral pathology. J Neurosci 2006;26:4752–4762.
81. Cai Z, Pan ZL, Pang Y, et al. Cytokine induction in fetal rat brains and brain injury in neonatal rats after maternal lipopolysaccharide administration. Pediatr Res 2000;47:64–72.
82. Garay PA, Hsiao EY, Patterson PH, et al. Maternal immune activation causes age- and region-specific changes in brain cytokines in offspring throughout development. Brain Behav Immun 2013;31:54–68.
83. Zuchero JB, Barres BA. Glia in mammalian development and disease. Development 2015;142:3805–3809.
84. Fourgeaud L, Boulanger LM. Role of immune molecules in the establishment and plasticity of glutamatergic synapses. Eur J Neurosci 2010;32:207–217.
85. Bilbo SD, Schwarz JM. The immune system and developmental programming of brain and behavior. Front Neuroendocrinol 2012;33:267–286.
86. Ehrlich KB, Ross KM, Chen E, et al. Testing the biological embedding hypothesis: is early life adversity associated with a later proinflammatory phenotype? Dev Psychopathol 2016;28:1273–1283.
87. Grissom NM, George R, Reyes TM. Suboptimal nutrition in early life affects the inflammatory gene expression profile and behavioral responses to stressors. Brain Behav Immun 2016;63:115–126.
88. Bolton JL, Bilbo SD. Developmental programming of brain and behavior by perinatal diet: focus on inflammatory mechanisms. Dialogues Clin Neurosci 2014;16:307–320.
89. Bolton JL, Huff NC, Smith SH, et al. Maternal stress and effects of prenatal air pollution on offspring mental health outcomes in mice. Environ Health Perspect 2013;121:1075–1082.
90. Madore C, Nadjar A, Delpech JC, et al. Nutritional n-3 PUFAs deficiency during perinatal periods alters brain innate immune system and neuronal plasticity-associated genes. Brain Behav Immun 2014;41:22–31.
91. Jasarevic E, Howerton CL, Howard CD, et al. Alterations in the vaginal microbiome by maternal stress are associated with metabolic reprogramming of the offspring gut and brain. Endocrinology 2015;156:3265–3276.
92. Etherton M, Foldy C, Sharma M, et al. Autism-linked neuroligin-3 R451C mutation differentially alters hippocampal and cortical synaptic function. Proc Natl Acad Sci USA 2011;108:13764–13769.
93. Hill-Yardin EL, Argyropoulos A, Hosie S, et al. Reduced susceptibility to induced seizures in the Neuroligin-3(R451C) mouse model of autism. Neurosci Lett 2015;589:57–61.
94. McFarlane HG, Kusek GK, Yang M, et al. Autism-like behavioral phenotypes in BTBR T+tf/J mice. Genes Brain Behav 2008;7:152–163.
95. Bercum FM, Rodgers KM, Benison AM, et al. Maternal stress combined with terbutaline leads to comorbid autistic-like behavior and epilepsy in a rat model. J Neurosci 2015;35:15894–15902.
96. Baca CB, Vickrey BG, Caplan R, et al. Psychiatric and medical comorbidity and quality of life outcomes in childhood-onset epilepsy. Pediatrics 2011;128:e1532–e1543.
97. Luoni C, Bisulli F, Canevini MP, et al. Determinants of health-related quality of life in pharmacoresistant epilepsy: results from a large multicenter study of consecutively enrolled patients using validated quantitative assessments. Epilepsia 2011;52:2181–2191.
98. Mechawar N, Savitz J. Neuropathology of mood disorders: do we see the stigmata of inflammation? Transl Psychiatry 2016;6:e946.
99. Leff-Gelman P, Mancilla-Herrera I, Flores-Ramos M, et al. The immune system and the role of inflammation in perinatal depression. Neurosci Bull 2016;32:398–420.
100. Kohler S, Cierpinsky K, Kronenberg G, et al. The serotonergic system in the neurobiology of depression: relevance for novel antidepressants. J Psychopharmacol 2016;30:13–22.
101. Stone EA, Lin Y, Quartermain D. A final common pathway for depression? Progress toward a general conceptual framework. Neurosci Biobehav Rev 2008;32:508–524.
102. Llorens-Martin M, Jurado-Arjona J, Bolos M, et al. Forced swimming sabotages the morphological and synaptic maturation of newborn granule neurons and triggers a unique pro-inflammatory milieu in the hippocampus. Brain Behav Immun 2016;53: 242–254.
103. Rossetti AC, Papp M, Gruca P, et al. Stress-induced anhedonia is associated with the activation of the inflammatory system in the rat brain: restorative effect of pharmacological intervention. Pharmacol Res 2016;103:1–12.
104. Macchi F, Homberg JR, Calabrese F, et al. Altered inflammatory responsiveness in serotonin transporter mutant rats. J Neuroinflammation 2013;10:116.
105. Carboni L, Becchi S, Piubelli C, et al. Early-life stress and antidepressants modulate peripheral biomarkers in a gene-environment rat model of depression. Prog Neuropsychopharmacol Biol Psychiatry 2010;34:1037–1048.
106. Fischer CW, Elfving B, Lund S, et al. Behavioral and systemic consequences of long-term inflammatory challenge. J Neuroimmunol 2015;288:40–46.
107. Fu X, Zunich SM, O'Connor JC, et al. Central administration of lipopolysaccharide induces depressive-like behavior in vivo and activates brain indoleamine 2,3 dioxygenase in murine organotypic hippocampal slice cultures. J Neuroinflammation 2010;7:43.
108. Gibney SM, McGuinness B, Prendergast C, et al. Poly I:C-induced activation of the immune response is accompanied by depression and anxiety-like behaviours, kynurenine pathway activation and reduced BDNF expression. Brain Behav Immun 2013;28:170–181.
109. Murray C, Griffin EW, O'Loughlin E, et al. Interdependent and independent roles of type I interferons and IL-6 in innate immune, neuroinflammatory and sickness behaviour responses to systemic poly I:C. Brain Behav Immun 2015;48:274–286.
110. Bruce TO. Comorbid depression in rheumatoid arthritis: pathophysiology and clinical implications. Curr Psychiatry Rep 2008;10:258–264.
111. Gao HX, Campbell SR, Cui MH, et al. Depression is an early disease manifestation in lupus-prone MRL/lpr mice. J Neuroimmunol 2009;207:45–56.
112. Pollak Y, Orion E, Goshen I, et al. Experimental autoimmune encephalomyelitis-associated behavioral syndrome as a model of ‘depression due to multiple sclerosis’. Brain Behav Immun 2002;16:533–543.
113. Anisman H, Gibb J, Hayley S. Influence of continuous infusion of interleukin-1beta on depression-related processes in mice: corticosterone, circulating cytokines, brain monoamines, and cytokine mRNA expression. Psychopharmacology 2008;199:231–244.
114. Hayley S, Scharf J, Anisman H. Central administration of murine interferon-alpha induces depressive-like behavioral, brain cytokine and neurochemical alterations in mice: a mini-review and original experiments. Brain Behav Immun 2013;31:115–127.
115. Kaster MP, Gadotti VM, Calixto JB, et al. Depressive-like behavior induced by tumor necrosis factor-alpha in mice. Neuropharmacology 2012;62:419–426.
116. Howerton AR, Roland AV, Bale TL. Dorsal raphe neuroinflammation promotes dramatic behavioral stress dysregulation. J Neurosci 2014;34:7113–7123.
117. Reus GZ, Jansen K, Titus S, et al. Kynurenine pathway dysfunction in the pathophysiology and treatment of depression: evidences from animal and human studies. J Psychiatr Res 2015;68:316–328.
118. Hochstrasser T, Ullrich C, Sperner-Unterweger B, et al. Inflammatory stimuli reduce survival of serotonergic neurons and induce neuronal expression of indoleamine 2,3-dioxygenase in rat dorsal raphe nucleus organotypic brain slices. Neuroscience 2011;184:128–138.
119. Guillemin GJ. Quinolinic acid: neurotoxicity. FEBS J 2012;279:1355.
120. Brambilla D, Franciosi S, Opp MR, et al. Interleukin-1 inhibits firing of serotonergic neurons in the dorsal raphe nucleus and enhances GABAergic inhibitory post-synaptic potentials. Eur J Neurosci 2007;26:1862–1869.
121. Myint AM, Steinbusch HW, Goeghegan L, et al. Effect of the COX-2 inhibitor celecoxib on behavioural and immune changes in an olfactory bulbectomised rat model of depression. NeuroImmunoModulation 2007;14:65–71.
122. Santiago RM, Barbiero J, Martynhak BJ, et al. Antidepressant-like effect of celecoxib piroxicam in rat models of depression. J Neural Transm (Vienna) 2014;121:671–682.
123. Arakawa S, Shirayama Y, Fujita Y, et al. Minocycline produced antidepressant-like effects on the learned helplessness rats with alterations in levels of monoamine in the amygdala and no changes in BDNF levels in the hippocampus at baseline. Pharmacol Biochem Behav 2012;100:601–606.
124. Molina-Hernandez M, Tellez-Alcantara NP, Perez-Garcia J, et al. Antidepressant-like actions of minocycline combined with several glutamate antagonists. Prog Neuropsychopharmacol Biol Psychiatry 2008;32:380–386.
125. Konsman JP, Veeneman J, Combe C, et al. Central nervous action of interleukin-1 mediates activation of limbic structures and behavioural depression in response to peripheral administration of bacterial lipopolysaccharide. Eur J Neurosci 2008;28:2499–2510.
126. Koo JW, Duman RS. IL-1beta is an essential mediator of the antineurogenic and anhedonic effects of stress. Proc Natl Acad Sci USA 2008;105:751–756.
127. Baharav E, Bar M, Taler M, et al. Immunomodulatory effect of sertraline in a rat model of rheumatoid arthritis. NeuroImmunoModulation 2012;19:309–318.
128. Obuchowicz E, Bielecka AM, Paul-Samojedny M, et al. Imipramine and fluoxetine inhibit LPS-induced activation and affect morphology of microglial cells in the rat glial culture. Pharmacol Rep 2014;66:34–43.
129. O'Sullivan JB, Ryan KM, Curtin NM, et al. Noradrenaline reuptake inhibitors limit neuroinflammation in rat cortex following a systemic inflammatory challenge: implications for depression and neurodegeneration. Int J Neuropsychopharmacol 2009;12:687–699.
130. Hashioka S. Antidepressants and neuroinflammation: can antidepressants calm glial rage down? Mini Rev Med Chem 2011;11: 555–564.
131. De Berardis D, Conti CM, Serroni N, et al. The effect of newer serotonin-noradrenalin antidepressants on cytokine production: a review of the current literature. Int J Immunopathol Pharmacol 2010;23: 417–422.
132. Mazarati A, Siddarth P, Baldwin RA, et al. Depression after status epilepticus: behavioural and biochemical deficits and effects of fluoxetine. Brain 2008;131:2071–2083.
133. Pineda EA, Hensler JG, Sankar R, et al. Plasticity of presynaptic and postsynaptic serotonin 1A receptors in an animal model of epilepsy-associated depression. Neuropsychopharmacology 2011;36:1305–1316.
134. Mazarati AM, Pineda E, Shin D, et al. Comorbidity between epilepsy and depression: role of hippocampal interleukin-1beta. Neurobiol Dis 2010;37:461–467.
135. Xie W, Cai L, Yu Y, et al. Activation of brain indoleamine 2,3-dioxygenase contributes to epilepsy-associated depressive-like behavior in rats with chronic temporal lobe epilepsy. J Neuroinflammation 2014;11:41.
136. Rush AJ, Trivedi MH, Wisniewski SR, et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry 2006;163: 1905–1917.
137. Baune BT, Dannlowski U, Domschke K, et al. The interleukin 1 beta (IL1B) gene is associated with failure to achieve remission and impaired emotion processing in major depression. Biol Psychiatry 2010;67:543–549.
138. Uher R, Perroud N, Ng MY, et al. Genome-wide pharmacogenetics of antidepressant response in the GENDEP project. Am J Psychiatry 2010;167:555–564.
139. Johansson D, Falk A, Marcus MM, et al. Celecoxib enhances the effect of reboxetine and fluoxetine on cortical noradrenaline and serotonin output in the rat. Prog Neuropsychopharmacol Biol Psychiatry 2012;39:143–148.
140. Pineda EA, Hensler JG, Sankar R, et al. Interleukin-1beta causes fluoxetine resistance in an animal model of epilepsy-associated depression. Neurotherapeutics 2012;9:477–485.